§610.68. Exceptions or alternatives to labeling requirements for biological products held by the Strategic National Stockpile. — Inbound Citations

(c) The appropriate FDA Center Director, according to the procedures set forth in §§ 201.26 or 610.68 of this chapter, may grant an exception or alternative to the provision in paragraph (a) of this section, to the extent that this provision is not explicitly required by statute, for specified lots, batches, or other units of a human drug product that is or will be included in the Strategic National Stockpile.

(E) A change made pursuant to an exception or alternative granted under § 201.26 or § 610.68 of this chapter.